Klothea Bio is a preclinical biotechnology company developing next-generation longevity therapeutics aimed at delaying age-related diseases. Its lead program uses a proprietary mRNA platform to boost endogenous secretion of soluble Klotho—a pleiotropic protein with potential benefits across multiple organ systems, including the brain, heart, kidneys, lungs, and bones.
By restoring Klotho levels diminished by aging, disease, or genetics, Klothea aims to unlock a new therapeutic pathway for enhancing health span. The company is targeting Phase 1 clinical trials in early 2026, with metabolic syndrome as the first planned indication.
Klothea is proud to partner with Healthy Longevity clinic that has been chosen as a semifinalist in the $101 million XPRIZE Healthspan competition for its approach to increase health span with our proprietary klotho mRNA therapy.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 195 Nw 40th St, Miami,florida 33127,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- mRNA, longevity, metabolic syndrome, neurodegeneration, cancer, heart health, kidney health, lung health, bone health, healthspan, lifespan.
- HQ
- Miami, Florida
Klothea Bio, Inc Questions
Klothea Bio, Inc's website is https://www.advantagetherapeutics.com
Klothea Bio, Inc's LinkedIn profile is https://www.linkedin.com/company/klothea-bio
Klothea Bio, Inc has
2 employees.
View email and phone details for 2
employees at Klothea Bio, Inc.
Klothea Bio, Inc's industry is
Biotechnology Research
Klothea Bio, Inc's top competitors are
对点咨询matchpoint,
Bench International,
Liberabio,
Klotho Therapeutics, Inc.,
Infinite Resource Solutions Inc.,
Massventures,
Advantage Therapeutics Inc.,
Gouya Insights,
Scitodate,
Think&action.
Klothea Bio, Inc's categories are Biotechnology Research
Klothea Bio, Inc's founding year is 2024
